Ironwood Pharmaceuticals (IRWD) Research & Development (2016 - 2025)
Historic Research & Development for Ironwood Pharmaceuticals (IRWD) over the last 17 years, with Q3 2025 value amounting to $22.5 million.
- Ironwood Pharmaceuticals' Research & Development fell 2467.23% to $22.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $98.7 million, marking a year-over-year decrease of 1893.25%. This contributed to the annual value of $111.4 million for FY2024, which is 401.77% down from last year.
- As of Q3 2025, Ironwood Pharmaceuticals' Research & Development stood at $22.5 million, which was down 2467.23% from $23.4 million recorded in Q2 2025.
- Ironwood Pharmaceuticals' 5-year Research & Development high stood at $35.7 million for Q4 2023, and its period low was $6.0 million during Q2 2023.
- In the last 5 years, Ironwood Pharmaceuticals' Research & Development had a median value of $22.5 million in 2025 and averaged $20.4 million.
- Per our database at Business Quant, Ironwood Pharmaceuticals' Research & Development tumbled by 6720.35% in 2022 and then soared by 40646.67% in 2024.
- Over the past 5 years, Ironwood Pharmaceuticals' Research & Development (Quarter) stood at $31.9 million in 2021, then plummeted by 67.2% to $10.4 million in 2022, then soared by 241.53% to $35.7 million in 2023, then dropped by 28.83% to $25.4 million in 2024, then decreased by 11.51% to $22.5 million in 2025.
- Its last three reported values are $22.5 million in Q3 2025, $23.4 million for Q2 2025, and $27.4 million during Q1 2025.